Tuan Vu, MD

Articles by Tuan Vu, MD

Presentation of Myasthenia Gravis (MG)

ByJames F. Howard, MD,Nicholas J. Silvestri, MD, FAAN,Tuan Vu, MD,Ali Habib, MD,Beth Stein, MD

March 26th 2024

Expert neurologists discuss the presentation of myasthenia gravis (MG), focusing on the variability of symptoms from patient to patient.

Understanding the ADAPT-SC Results of Subcutaneous Efgartigimod: Tuan Vu, MD

ByTuan Vu, MD

November 2nd 2023

The division director of Neuromuscular Medicine & EMG at USF Health provided an overview of the open-label findings from ADAPT-SC, a phase 3 study assessing subcutaneous efgartigimod in patients with myasthenia gravis. [WATCH TIME: 3 minutes]

Tuan Vu, MD

Articles by Tuan Vu, MD

Presentation of Myasthenia Gravis (MG)

Understanding the ADAPT-SC Results of Subcutaneous Efgartigimod: Tuan Vu, MD

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Using Serum Biomarkers to Monitor Multiple Sclerosis Disease Activity: Darin T. Okuda, MD, FAAN, FANA

Improving Recognition of Autonomic Dysfunction in Parkinson Disease: Insights With Jonathan Isaacson, MD; and Abhishek Lenka, MD, PhD

NeurologyLive® Brain Games: June 28, 2026

Tolebrutinib Approved in EU for Nonrelapsing Secondary Progressive MS, Marking First Disability-Targeting Therapy in the Indication

Clinical Impact of FDA's Expanded Efgartigimod Label: Josh Alpers, MD